Independent Panel Set to Assess Hepatitis B Vaccine Data Following CDC Delay

An independent panel will review data on the Hepatitis B vaccine after the CDC delayed a vote on its administration at birth, impacting vaccination guidelines.

• The Vaccine Integrity Project, a group of U.S. vaccine experts, will assess data supporting the Hepatitis B vaccine recommendation by early December.
• This review follows a postponement by the Centers for Disease Control and Prevention on voting to delay the first dose of the Hepatitis B shot at birth.
• The decision to evaluate the Hepatitis B vaccine data underscores ongoing discussions about vaccination protocols in the U.S. and their implications for public health.